Joanne Bell Selected Research

SAM-760

1/2018

A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer's disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joanne Bell Research Topics

Disease

4	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 07/2011
2	Dementia (Dementias) 01/2020 - 07/2011
1	Psychotic Disorders (Schizoaffective Disorder) 01/2020
1	Hallucinations (Hallucination) 01/2020
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2020
1	Lymphoma (Lymphomas) 10/2016
1	Neutropenia 10/2016
1	Stroke (Strokes) 07/2011

Drug/Important Bio-Agent (IBA)

2	Receptor for Advanced Glycation End ProductsIBA 04/2014 - 07/2011
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	SAM-760IBA 01/2018
1	serotonin 6 receptorIBA 01/2018
1	Donepezil (Aricept)FDA LinkGeneric 01/2018
1	plerixafor FDA Link 10/2016
1	antineoplaston A10 (A 10)IBA 07/2011

Therapy/Procedure

1	Blood Component Removal (Apheresis) 10/2016
1	Autologous Transplantation 10/2016